Acepodia, Inc. (TPEX:6976)
Taiwan
· Delayed Price · Currency is TWD 12.75
+0.40 (3.24%)
Apr 29, 2026, 1:53 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 7.19 billion as of April 28, 2026. Its market cap has decreased by -32.07% in one year.
Market Cap
7.19B
Enterprise Value
3.65B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.75
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 7.19B, a decrease of -68.63%. That is a compound annual growth rate of -34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 7.19B | -19.54% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 7.19B |
| Adimmune | 7.54B |
| PharmaEngine | 7.82B |
| Gongwin Biopharm Holdings | 7.95B |
| Mycenax Biotech | 6.08B |
| Sinphar Pharmaceutical | 6.02B |
| Savior Lifetec | 6.01B |
| AnnJi Pharmaceutical | 5.94B |